Evaluation of Prescription Adaptation Following Changes to A Provincial Drug Insurance Formulary

On 1 December 2016, British Columbia’s (BC) provincial drug insurance program changed which medications in certain classes would benefit under the insurance program in an attempt to reduce expenditure. As part of the modernization, HMG-CoA reductase inhibitors (Statins), Angiotensin converting enzym...

Descripción completa

Detalles Bibliográficos
Autor principal: Pammett, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473338/
https://www.ncbi.nlm.nih.gov/pubmed/30621002
http://dx.doi.org/10.3390/pharmacy7010006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473338/
https://www.ncbi.nlm.nih.gov/pubmed/30621002
http://dx.doi.org/10.3390/pharmacy7010006

Ejemplares similares